Pharma & Biotech Mergers & Acquisitions News
Pharmaceutical
Big pharmas are not deterred by China’s increasingly complex business environment. Instead, they are changing strategies to minimize risks while continuing to benefit from China, said speakers at ChinaTrials held last week in Shanghai. 18 November 2024
Today's issue
Refine Search
Latest Mergers & Acquisitions News & Features
Generics
Indian drugmaker Lupin Limited has entered into a definitive agreement through its Japanese subsidiary Kyowa for the sale of its Japanese Injectables business and related assets in Japan to neo ALA Co, a wholly-owned subsidiary of Neopharma group, the UAE’s largest pharmaceutical manufacturer headquartered in Abu Dhabi. 22 August 2019
Generics
German generics major Stada Arzneimittel has continued to deliver significant growth by generating strong first-half 2019 results, with the company’s shares gaining 1.08% at 83.90 euros by close of trading on Wednesday. 15 August 2019
Generics
Drug trial news last week included disappointment for Novartis, as its heart drug Entresto failed to show statistical significance in an HFpEF Phase III trial, but good news for Alkermes and Biogen with positive new data on Vumerity which showed statistical superiority over Tecentriq in multiple sclerosis. News that US pharma giant Pfizer would merge its generics operations with Mylan elicited significant comment. On the deal-making front, there was bad news for Sweden’s Alligator Biosciences, when partner Janssen, part of Johnson & Johnson, decided to return rights to their partnered cancer drug candidate ADC-1013. 4 August 2019
Generics
A generics powerhouse worth some $20 billion in revenues is to be created by the merger of Netherlands-incorporated Mylan and the off-patent business of New York-based pharma giant Pfizer. 29 July 2019
Generics
Swiss pharmaceutical and biotech ingredient supplier Lonza today announced its intention to proceed with a carve-out of its Specialty Ingredients segment (LSI). 3 June 2019
Generics
UK-based asset manager Investment Group Capital (IGC) and French healthcare-focused investment platform Mérieux Equity Partners have agreed to acquire DOC Generici from CVC Capital Partners. 9 April 2019
Generics
In a second acquisition this year, Czech Republic-based generics drugmaker Zentiva Group announced it has bought Creo Pharmaceuticals in the UK, a subsidiary of Amneal Pharmaceuticals. 1 April 2019
Generics
A majority equity stake in British active pharmaceutical ingredients (API) contract development and manufacturing organization Sterling Pharma Solutions has been acquired by GHO Capital following its impressive growth. 14 March 2019
Generics
Zentiva Group and Siyiara Enterprises have signed a shared purchase agreement for the acquisition of Romanian based pharmaceutical company Solacium, together with its subsidiary Be Well Pharma. 13 March 2019
Generics
Italian active pharmaceutical ingredients (API) contract development and manufacturing organization (CDMO) Olon SpA and generics supplier, today announced the acquisition of Capua BioServices SpA, a global provider of CDMO services in the field of microbial fermentation. 25 January 2019
Generics
Hetero Labs, one of India’s leading generic pharmaceutical companies and the world’s largest producer of anti-retroviral drugs, today announced that its European subsidiary Amarox has acquired Tarbis Farma. 2 January 2019
Generics
Activity in the pharma sector is rife in India, with mergers and acquisition deal values doubling given revived domestic and cross-border deal activity. Technology in the form of Artificial Intelligence and Big Data has also come to the aid of the pharmaceutical industry, reports The Pharma Letter’s India correspondent. 12 December 2018
Generics
Fresenius saw its worst share price fall ever on Friday, after the German healthcare group issued a profit warning, the previous day. Its share plunged 17.71% to 38.00 euros by close. 8 December 2018
Generics
German drugmaker Stada Arzneimittel has increased its indirect shareholding in the Vietnamese pharmaceutical company Pymepharco JSC to 72%, in which it has been a strategic since 2008. 7 December 2018
Generics
Months after reports indicated that Aurobindo Pharma would bid for the generics firm Sandoz, parent company Novartis announced it had accepted an offer of around $1 billion from the Indian drugmaker. 7 September 2018
Generics
P&R Group affiliate active pharmaceutical ingredients (API) contract development and manufacturing organization (CDMO) Olon has acquired a local generics chemical operations API manufacturing facility in Mahad, India, as part of a continuing expansion of its global footprint. 4 September 2018
Generics
Having announced in April that it is discussing the sale of Zentiva, French pharma major Sanofi says it has now concluded negotiations for the acquisition of its European generics business, by Advent International. 28 June 2018
Generics
Switzerland’s Novartis is moving to offload its American dermatology business and oral treatments division, among other assets, for up to $2 billion. 14 May 2018
Generics
Indian generics drugmaker Strides Arcolab will soon have a controlling interest in the largest player in the Australian generics market. 9 May 2018
Generics
The US Federal Trade Commission will require generic drug marketers privately-held Amneal Pharmaceuticals and Impax Laboratories to divest Impax’ rights and assets for 10 products to three other companies, as part of a settlement resolving charges that Amneal’s $1.45 billion acquisition of an equity share in Impax, announced last October, likely would be anticompetitive. 30 April 2018
Generics
Aspire Pharma, a UK-based niche generics business, has announced the acquisition of all assets from Canute Pharma, further expanding its product range. 4 October 2024
Generics
Viatris has announced that the antitrust division of the US Department of Justice (DOJ) has concluded its investigation into Mylan and its former president, Rajiv Malik. 3 July 2024
Generics
An activist investor has renewed its effort to prevent Taro Pharmaceutical from accepting a buyout bid from Sun Pharmaceutical. 24 April 2024
Generics
Generic drugmaker Apotex has reached an agreement to acquire fellow Canada-based Searchlight Pharma. 5 April 2024
Generics
KELIX bio, an emerging markets biopharmaceuticals platform, has been sold to Mubadala Investment Company, an Abu Dhabi investor with over $276 billion in assets under management. 25 March 2024
Generics
Generic drugmaker Aspire Pharma today announced the successful completion of its acquisition of fellow UK-based Cenoté Pharma, in continuation of its strong organic growth. 11 March 2024
Generics
In a bid to focus on growth and innovation, Israeli generics drugmaker Teva Pharmaceutical is to hive off its active pharmaceutical ingredient (API) business. 1 February 2024
Generics
Sun Pharmaceutical Industries of India announced its intention to acquire all outstanding shares of US generics drugmaker Taro Pharmaceutical Industries at a price of $43 per share in cash, the companies announced. 19 January 2024
Generics
Taiwan’s Bora Pharmaceuticals is to acquire Upsher-Smith Laboratories, a US generics manufacturer. 17 January 2024
Generics
South Africa's largest drugmaker Aspen Pharmacare has announced an agreement with newly-independent generics drugmaker Sandoz, related to its Chinese business. 7 December 2023
Generics
Portuguese contract development and manufacturing organization (CDMO) Hovione has acquired the start-up ExtremoChem for an undisclosed amount. 20 November 2023
Generics
The Indian pharma and healthcare sector has witnessed a 298% jump in deals during the third quarter of 2023 compared to the same period last year. 8 November 2023
Generics
A confluence of factors is creating a conducive environment for mergers and acquisitions (M&As) to pick up pace in India. 23 October 2023
Generics
USA-based drugmaker Viatris has announced a series of divestitures as part of a strategy to narrow the company’s focus. 3 October 2023
Generics
Indian drugmaker Glenmark Pharmaceuticals has entered into a definitive agreement with Nirma Limited to divest a 75% stake in its subsidiary, Glenmark Life Sciences Limited (GLS), which focuses on producing active pharmaceutical ingredients (APIs). 22 September 2023
Generics
Shares of Hyderabad, India-headquartered Suven Pharmaceuticals hit a fresh 52-week high on the bourses after the Indian government gave the green signal to foreign direct investment (FDI) of up to $1.15 billion by drug major Cyprus-based Berhyanda. 19 September 2023
Generics
Several international investors and fund managers have expressed an interest in investing in the Indian pharmaceutical and biotechnology sectors, underlining the need to establish a platform to facilitate the transition of global capital flows into the domestic economy. 14 April 2023
Generics
In what could well be India's biggest pharma deal, China's Fosun Pharma-owned Gland Pharma is on the block. A number of private equity firms have been approached, including Baring Private Equity, Bain Capital, Blackstone, Carlyle, and KKR. 19 December 2022
Generics
Generics major Viatris yesterday said it intends to create an ophthalmology franchise by acquiring two companies, Oyster Point Pharma (Nasdaq: OYST) and Famy Life Sciences. 8 November 2022
Generics
Private equity firm SK Capital Partners has entered into a deal to acquire Apotex Pharmaceutical Holdings, a Canada-based generic drugmaker with products across all major therapeutic areas for patients around the world. 29 September 2022
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze